Aortic regurgitation and Churg-Strauss syndrome.

patients are using appropriate pharmacotherapy and are clinically stable, there is understandably a disinclination to titrate therapy downwards, in case one offsets the control of asthma, which has been difficult to attain in the first instance. In conclusion, secondary care physicians need to have a heightened awareness in terms of steppingdown ICS therapy in stable asthmatics. Failing to do so may expose patients to unnecessary and prolonged treatment with high doses of ICS.